Drugs like Wegovy can be effective at treating fatty liver disease

A recent trial found that semaglutide, the active ingredient in weight-loss drugs like Wegovy, demonstrated significant benefits for patients with metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease. The results suggest potential new therapeutic applications for the medication beyond weight management.